Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881491 · ClinicalTrials.gov registry record · Early Phase 1
Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste
A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT00881491 is a Early Phase 1 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 10 participants.
The verdict
NCT00881491, a Early Phase 1 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the treatment outcomes in permanent teeth with necrotic pulp and immature root development that undergo a regenerative procedure using a triple antibiotic paste (ciprofloxacin, metronidazole, minocycline) versus a double antibiotic paste (ciprofloxacin, metronidazole)compared to the commonly used mineral trioxide aggregate (MTA) apexification treatment.
Interventions
- DRUG Mineral Trioxide Aggregate
- DRUG Triple Antibiotic Paste
- DRUG Double Antibiotic Paste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-04 |
| Est. Completion | 2015-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00881491
The ClinicalTrials.gov registry entry for NCT00881491 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Mineral Trioxide Aggregate is the first listed.
NCT00881491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00881491 about?
NCT00881491 is a clinical study titled "Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste". The purpose of this study is to determine the treatment outcomes in permanent teeth with necrotic pulp and immature root development that undergo a regenerative procedure using a triple antibiotic paste (ciprofloxacin, metronidazole, minocycline) versus a double antibiotic paste (ciprofloxacin, metr...
What is the current status of trial NCT00881491?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2009-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00881491?
The interventions under investigation include: Mineral Trioxide Aggregate (DRUG), Triple Antibiotic Paste (DRUG), Double Antibiotic Paste (DRUG).
Who is sponsoring clinical trial NCT00881491?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.